Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.290
+0.180 (5.79%)
At close: Mar 30, 2026, 4:00 PM EDT
3.220
-0.070 (-2.13%)
Pre-market: Mar 31, 2026, 5:25 AM EDT
Alvotech Market Cap
Alvotech has a market cap or net worth of $1.03 billion as of March 31, 2026. Its market cap has decreased by -69.79% in one year.
Market Cap
1.03B
Enterprise Value
2.31B
1-Year Change
-69.79%
Ranking
Category
Stock Price
$3.29
Market Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $1.03B, an increase of 238.00%. That is a compound annual growth rate of 25.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 1.03B | -35.87% |
| Dec 31, 2025 | 1.61B | -59.76% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ANI Pharmaceuticals | 1.54B |
| Amylyx Pharmaceuticals | 1.41B |
| Perrigo Company | 1.34B |
| Harrow | 1.24B |
| Collegium Pharmaceutical | 1.02B |
| Pacira BioSciences | 942.20M |
| Cronos Group | 925.60M |
| Amphastar Pharmaceuticals | 872.01M |